期刊文献+

因卡膦酸二钠治疗乳腺癌骨转移临床观察 被引量:1

下载PDF
导出
摘要 目的观察因卡膦酸二钠治疗乳腺癌骨转移疼痛和改善活动能力的效果。方法选取2011年5月-2013年5月收治的80例患乳腺癌骨转移的患者,随机分成治疗组和对照组各40例,治疗组进行因卡膦酸二钠治疗,对照组进行帕米膦酸二钠治疗,比较治疗后两组患者疼痛和活动能力的情况。结果止痛效果:治疗组总有效率为87.5%,对照组总有效率是85.0%,差异无统计学意义(P〉0.05);活动能力情况:治疗组和对照组总有效率分别是77.5%和75.0%,差异无统计学意义(P〉0.05);发热情况:治疗组和对照组发热率分别是0和15.0%,差异有统计学意义(P〈0.05)。结论因卡膦酸二钠在缓解骨疼痛和提高活动能力上与帕米膦酸二钠效果相似,但是不良反应较轻。
出处 《中国处方药》 2014年第12期65-65,共1页 Journal of China Prescription Drug
  • 相关文献

参考文献3

二级参考文献30

  • 1陶莉,王洪林,陈剑,李纲,王妹兴,李安琪,王中吉.唑来膦酸治疗76例恶性肿瘤骨转移性疼痛[J].中国癌症杂志,2006,16(12):1057-1059. 被引量:11
  • 2[1]Akhtari M,Mansuri J,Newman K A,et al.Biology of breast cancer bone metastasis.Cancer Biol Ther,2008:7:3-9.
  • 3[4]Yavas O,Hayran M,Ozisik Y.Factors affecting survival in breast cancer patients following bone metastasis.Tumori,2007,93:580-586.
  • 4[5]Green J R,Muller K,Jaeggi K A.Preclinical pharmacology of CGP 42'446:a new,potent,heterocyclic bisphosphonate compound.J Bone Miner Res,1994,9:745-751.
  • 5[6]King A E,Umland E M.Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.Pharmacotherapy,2008,28:667-677.
  • 6[7]McKeage K,Plosker G L.Zoledronic acid:a pharmacoeconomic review of its use in the management of bone metastases.Pharmacoeconomics,2008,26:251-268.
  • 7[8]Senaratne S G,Pirianov G,Mansi J L,et al.Bisphosphonates induce apoptosis in human breast cancer cell lines.Br J Cancer,2000,82:1459-1468.
  • 8[9]Boissier S,Ferreras M,Peyruchaud O,et al.Bisphosphonates inhibit breast and prostate carcinoma cell invasion:an early event in the formation of bone metastases.Cancer Res,2000,60:2949-2954.
  • 9[10]Wood J,Bonjean K,Ruetz S,et al.Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.J Pharmacol Exp Ther,2002,302:1055-1061.
  • 10Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solidtumors: a phase Ⅲ, double-blind, randomized trial-The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group [J]. J Clin 0ncol,2003,21 (16) :3150.

共引文献22

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部